²é¿´: 1061  |  »Ø¸´: 2

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

[½»Á÷] Ìì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÕÔÀö½ÌÊÚ¿ÎÌâ×齲ʦ¡¢²©ºó¼°¿ÆÑÐÖúÀíÕÐÆ¸

¾ßÌ幤×÷µØµã:
Ìì½òÊÐºÍÆ½ÇøÆøÏǫ́·22ºÅÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§Ôº
н½ð:
ÔÂн°ËǧÖÁÒ»Íò
ѧÀúºÍÑо¿·½Ïò:
ÉúÎҽѧ¡¢Ò©Ñ§µÈ
ÕÐÆ¸¸Úλ:
½²Ê¦/²©ºó/¿ÆÑÐÖúÀí
¹«Ë¾Ãû³Æ:
Ìì½òÒ½¿Æ´óѧ
ÁªÏµ·½Ê½:
shzhaoli@tmu.edu.cn

¿ÎÌâ×é½éÉÜ
       ÕÔÀö½ÌÊÚΪÌì½òÒ½¿Æ´óѧ»ù´¡Ò½Ñ§ÔºÉúÎﻯѧÓë·Ö×ÓÉúÎïѧϵ½ÌÊÚ£¬Ìì½òÊÐÌØÆ¸½ÌÊÚ£¬²©Ê¿Éúµ¼Ê¦¡£
       ¿ÎÌâ×鳤ÆÚÖÂÁ¦ÓÚÁ˽âÏÂÇðÄÔ-´¹Ì壬¼××´ÏÙ£¬ÈéÏÙµÈÉñ¾­ÄÚ·ÖÃÚ»·Â·ÖÐµÄÆ÷¹Ù·¢Óý£¬²¢ÒÔ´ËÍÆ½ø¶ÔÏà¹Ø¼²²¡ºÍ°©Ö¢·¢Éú»úÖÆµÄÀí½â¡£ÀûÓÃת»ùÒòСÊó¹¹½¨¸÷ÖÖÌù½üÁÙ´²ÉúÀí¼²²¡ºÍ°©Ö¢µÄ¶¯Îï¼²²¡Ä£ÐÍ£»½Òʾ²¢×·×ÙÆ÷¹Ù·¢ÓýºÍÖ×Áö·¢ÉúµÄ¹Ø¼üÆðʼϸ°ûµÄ£»ÒÔǰÆÚ·Ö×Ó»úÖÆÍÚ¾òºÍÄÉÃ×°ÐÏòÒ©ÎïµÄ¿ª·¢ÓëµÝËÍΪ»ù´¡£¬Îª°©Ö¢ÖÎÁÆÌرðÊÇÄÑÖÎÐÔ¡¢×ªÒÆÐÔ°©Ö¢µÄÖÎÁÆÌṩ°ÐÏòÐÔÓëÓÐЧÐԸߡ¢¸±×÷ÓÃСµÄÖÎÁƲßÂÔ¡£
¿ÎÌâ×é³É¹û£º
       ·¢±íÔÚMolecular Cell¡¢Developmental Cell¡¢Nature Communications¡¢Development¡¢Oncogene¡¢Journal of Bone and Mineral Research¡¢ACS NanoµÈÔÓÖ¾20ÓàÆª¡£
1. Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L. (2024) Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.Nat Commun. 15(1):4108.
2. Zhang P, Guan L, Sun W, Zhang Y, Du Y, Yuan S, Cao X, Yu Z, Jia Q, Zheng X, Meng Z, Li X, Zhao L.(2024) Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAFV600E-associated thyroid carcinoma. Clin Transl Med. 14(5):e1694.
3. Su Y, Luo Y, Zhang P, Lin H, Pu W, Zhang H, Wang H, Hao Y, Xiao Y, Zhang X, Wei X, Nie S,Zhang K, Fu Q, Chen H, Huang N, Ren Y, Wu M, Chow BKC, Chen X, Jin W, Wang F, Zhao L*, Rao F*. (2023) Glucose-induced CRL4COP1-p53 axis amplifies glycometabolism to drive tumorigenesis. Mol Cell. 83(13):2316-2331.e7.
4¡¢Zhang P, Guan H, Yuan S, Cheng H, Zhang Z, Zheng J, Yu Y, Meng Z, Zheng X, Zhao L*. (2022) Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors. Nat Commun. 13(1):1588
5¡¢Yuan S, Zhang P, Wen L, Jia S, Wu Y, Zhang Z, Guan L, Yu Z, Zhao L*. (2021) miR-22 promotes stem cell traits via activating Wnt/¦Â-catenin signaling in cutaneous squamous cell carcinoma. Oncogene. 40(39):5799-5813
6¡¢Bi X, Lou P, Song Y, Sheng X, Liu R, Deng M, Yang X, Li G, Zhang B, Xue L, Liu Z, Plikus M, Ren F, Gao S, Yuan S, Zhang H, Jiao B, Zhao L*, Yu Z* (2021) Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. Oncogene. 40(29):4832-4845
ÕÐÆ¸¸Úλ¼°ÒªÇó£º
1. ¿ÆÑÐÖúÀí1Ãû£ºÄêÁä¡Ü30ÖÜË꣬¾ßÓÐ˶ʿÑо¿Éú¼°ÒÔÉÏѧÀúºÍѧ룬ÉúÎҽѧ¡¢Ò©Ñ§µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡ÊìÁ·ÕÆÎÕϸ°ûÅàÑø¡¢»ù±¾µÄÉú»¯ºÍ·Ö×ÓÉúÎïѧʵÑé¼¼ÄÜ£¬µÚ1×÷Õß·¢±íÓÐSCIÂÛÎÄÕßÓÅÏÈ¡£
2. ½²Ê¦1Ãû£¬²©Ê¿ºó1Ãû£ºÄêÁä¡Ü35ÖÜË꣬¾ßÓв©Ê¿Ñо¿ÉúѧÀúºÍѧ룬Ö×Áö¡¢ÌÇÖ¬´úлºÍ±í¹ÛÒÅ´«µÈÏà¹Ø×¨Òµ·½Ïò¡£ÈȰ®¿ÆÑУ¬³Ô¿àÄÍÀÍ£¬¾ßÓÐÍŶÓЭ×÷¾«Éñ£¡È¡µÃ½ÏºÃµÄÑо¿³É¹û£¨ÒÔµÚ1×÷Õß·¢±íQ1ÇøSCIÂÛÎÄÕßÓÅÏÈ£©²¢ÇҾ߱¸Á¼ºÃµÄ·¢Õ¹Ç±Á¦£»¾ßÓжÀÁ¢µÄ¿ÎÌâÉè¼ÆÄÜÁ¦ºÍÔúʵµÄʵÑé²Ù×÷ÄÜÁ¦£¬Äܹ»ÔÚPIµÄÖ¸µ¼Ï¶ÀÁ¢Õ¹¿ªÑо¿¹¤×÷£¬²¢²ÎÓëÑо¿ÉúµÄÖ¸µ¼¹¤×÷¡£

н³ê´ýÓö£º
1. ´ýÓö²ÎÕÕÌì½òÒ½¿Æ´óѧÏà¹ØÈËÊÂÕþ²ß²¢´ÓÓÅ¡£
2. Ìṩ¿ÆÑÐÖ¸µ¼£¬²Î¼Ó¹úÄÚÍâѧÊõ»áÒéµÄ»ú»á£¬È«Á¦Ö§³ÖÉêÇë¸÷ÖÖ»ù½ðºÍÈ˲ÅÏîÄ¿¡£
3. ¿ÆÑÐÖúÀíÒµÎñÊìÁ·Õß¿ÉÍÆ¼ö¼ÌÐø¶Á²©

»¶Ó­Ö¾È¤ÏàͶ¡¢ÈȰ®¿ÆÑС¢Çڷܿ̿àµÄ¿ÆÑÐÖúÀí¡¢²©Ê¿ºóºÍ½²Ê¦Ó¦Æ¸Õß¼ÓÈë¿ÎÌâ×飡
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

½ðÔÀÔÀÔÀÒ©

гæ (³õÈëÎÄ̳)

½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð
2Â¥2025-02-26 10:37:19
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

ÓÐÈË¿´µ½ÎҵĶú»

Ìú³æ (³õÈëÎÄ̳)

ÒýÓûØÌû:
2Â¥: Originally posted by ½ðÔÀÔÀÔÀÒ© at 2025-02-26 10:37:19
½ñÄê6Ô²űÏÒµ¿ÉÒÔÂð

µ±È»¿ÉÒÔѽ
3Â¥2025-04-16 17:19:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ ÓÐÈË¿´µ½ÎҵĶú» µÄÖ÷Ìâ¸üÐÂ
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û